Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

Key facts

Where
Buffalo, Columbia, Detroit, Hershey, Kingsport, Maywood, Miami Beach, Minneapolis, New Brunswick, Raleigh, Richmond, Royal Oak, St Louis, Stony Brook, Toledo, and Washington, United StatesSee the 16 sites

Where in United States

  • Sisters of Charity HospitalBuffalo, United StatesContact: P Anain, MD (principal investigator)Taking people
  • University of MissouriColumbia, United StatesContact: T. Vogel, MD (principal investigator)Taking people
  • Henry Ford HospitalDetroit, United StatesContact: Dr. Mitchel WeaverNot yet recruiting
  • Penn State Health Milton S. Hershey Medical CenterHershey, United StatesContact: Dr. Faisal Aziz, MDTaking people
  • Ballad Health/Holston ValleyKingsport, United StatesContact: R. Allen, MD (principal investigator)Taking people
  • LoyolaMaywood, United StatesContact: P. Dr. Halandras, MDTaking people
  • Mt Sinai Med CtrMiami Beach, United StatesContact: M Ayad, MD (principal investigator)Taking people
  • Alina HealthMinneapolis, United StatesContact: J. Jim, MD (principal investigator)Taking people
  • Robert Wood Johnson University Medical CenterNew Brunswick, United StatesContact: Beckerman, MD (principal investigator)Taking people
  • NC Heart& VascularRaleigh, United StatesContact: R. Mendez, MD (principal investigator)Taking people
  • Virginia Commonwealth University (Vcu)Richmond, United StatesContact: Newton, MD (principal investigator)Taking people
  • Beaumont University HospitalRoyal Oak, United StatesContact: O.W. Brown, MD (principal investigator)Taking people
  • Barnes-Jewish HospitalSt Louis, United StatesContact: L Sanchez, MD (principal investigator)Taking people
  • Stony Brook University Medical CenterStony Brook, United StatesContact: A. Tassiopoulos, MD (principal investigator)Taking people
  • ProMedica Toledo HospitalToledo, United StatesContact: B. Aplin, MD (principal investigator)Taking people
  • Washington Regional Medical CenterWashington, United StatesContact: R. Wood, MD (principal investigator)Taking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Rijnstate Hospital
Trial code
NCT05484115
Record updated
11 May 2026
Original description
The HERCULES trial is a Randomized controlled clinical trial designed to prospectively compare endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR) clinical outcomes in treatment of infrarenal abdominal aortic aneurysm (AAA) in subjects having wide proximal aortic neck diameters (≥ 28mm and ≤ 32mm).Read full original descriptionShow less

Randomized Controlled Clinical Trial on the Application of Heli-FX EndoAnchors in Conjunction With the Endurant II/IIs Endograft in Infrarenal Aortic Aneurysms With a Wide Infrarenal Neck (HERCULES Trial)

The HERCULES trial is a Randomized controlled clinical trial designed to prospectively compare endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR) clinical outcomes in treatment of infrarenal abdominal aortic aneurysm (AAA) in subjects having wide proximal aortic neck diameters (≥ 28mm and ≤ 32mm).

Inclusion: Age 18 years or older; Provided written informed consent; Clinical necessity for treatment of the AAA, according to the current guidelines in the geographies participating; Elective repair; Eligible anatomy for treatment with the Endurant II/IIs stent graft system and Heli-FX EndoAnchor system according to the IFU of both devices; Infrarenal neck diameter ≥ 28 mm and ≤32 mm; Proximal neck length ≥10mm.

Exclusion: Patient had a Cerebro Vascular Accident (CVA) or a myocardial infarction (MI) within the prior three months; Patient has active COVID-19 infection or has been diagnosed with long COVID-19 requiring hospitalization within the 6 months prior to procedure; Patient has previously been treated with stent grafts in the aorto-iliac arteries; Patient has a psychiatric or other condition that may interfere with the study; Patient has a known allergy to any device component; Patients with a systemic infection who may be at increased risk of endovascular graft infection; Patient has a coagulopathy or uncontrolled bleeding disorder; Patient with eGFR < 30 ml/min/1.73m2 before the intervention; Patient's life expectancy <2 years as judged by the investigator; Anatomy outside the IFU of the ndurant II/IIs stent graft system and Heli-FX EndoAnchor system; Planned use of AUI main body device; Patient is participating in another clinical study, potentially conflicting with the outcomes of the current study; Patient has a ruptured, leaking, or mycotic aneurysm; Patient is not eligible for standard EVAR; Patient is pregnant (Female patients of childbearing potential only).

ClinicalTrials.gov NCT05484115